www.fdanews.com/articles/108909-liver-cancer-patients-live-longer-with-anti-cancer-drug
Liver Cancer Patients Live Longer With Anti-Cancer Drug
July 25, 2008
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug.
ScienceDaily
ScienceDaily